Drugs / Polyethylene glycol with electrolytes
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01685853 Comparator | Apr 2011 → Mar 2012 | — | European Institute of Oncology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyethylene glycol with electrolytes | “Polyethylene glycol with electrolytes (PEG)” NCT01685853 ↗ |
| Known as | PEG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01685853 ↗ |